BW
BIIB icon

Basepoint Wealth’s Biogen BIIB Stock Holding History

Basepoint Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
1,178
+14
+1% +$2.58K 0.12% 99
2025
Q4 		$205K Buy
+1,164
New +$190K 0.12% 95
2025
Q1 		– Sell
-1,590
Closed -$243K – 104
2024
Q4 		$243K Sell
1,590
-347
-18% -$58.5K 0.19% 88
2024
Q3 		$376K Sell
1,937
-291
-13% -$60.9K 0.28% 70
2024
Q2 		$517K Sell
2,228
-356
-14% -$77.4K 0.41% 60
2024
Q1 		$557K Sell
2,584
-95
-4% -$22.2K 0.42% 60
2023
Q4 		$693K Sell
2,679
-101
-4% -$24.8K 0.56% 46
2023
Q3 		$714K Sell
2,780
-24
-0.9% -$6.42K 0.58% 41
2023
Q2 		$799K Sell
2,804
-16
-0.6% -$4.76K 0.66% 41
2023
Q1 		$784K Sell
2,820
-105
-4% -$29.1K 0.65% 40
2022
Q4 		$810K Sell
2,925
-75
-3% -$21.2K 0.72% 36
2022
Q3 		$801K Sell
3,000
-42
-1% -$8.92K 0.85% 25
2022
Q2 		$620K Sell
3,042
-185
-6% -$37.8K 0.65% 37
2022
Q1 		$680K Sell
3,227
-385
-11% -$83.7K 0.63% 29
2021
Q4 		$867K Buy
+3,612
New +$929K 0.85% 24

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Basepoint Wealth's BIIB Position: Q1 2026 in Review

Basepoint Wealth increased its Biogen (BIIB) stake by 1.2% in Q1 2026, buying an estimated $2.58K and bringing the position to 1,178 shares worth $216K. The position accounts for 0.12% of the portfolio, ranked #99.

Basepoint Wealth first reported a position in BIIB in Q4 2021 and has held it in 15 quarters since. The position peaked at $867K in Q4 2021. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Basepoint Wealth held 1,178 shares of Biogen worth $216K as of Q1 2026.
  • Basepoint Wealth bought 14 Biogen shares in Q1 2026, an estimated $2.58K.
  • Biogen made up 0.12% of Basepoint Wealth's portfolio in Q1 2026, its #99 holding.
  • Basepoint Wealth first reported a position in Biogen in Q4 2021 and has held it in 15 quarters since.
  • Basepoint Wealth's Biogen position peaked at $867K in Q4 2021.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.